Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
30.06. | Mabion, NovalGen Partner to Bring NVG-222 to Market | 1 | Contract Pharma | ||
MABION Aktie jetzt für 0€ handeln | |||||
18.06. | Mabion Launches €500,000 Oncology Services Contest | 1 | Contract Pharma |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BIONTECH | 94,25 | -2,23 % | BioNTech Aktie: In welche Richtung wird es gehen? | © Foto: fn SymbolbildDas deutsche Biotech-Unternehmen BioNTech steht vor einer großen Veränderung. Die erfolgreiche Zeit mit Corona-Impfstoffen geht stetig weiter zu Ende. Jetzt arbeitet das Mainzer... ► Artikel lesen | |
CUREVAC | 4,742 | +0,30 % | CureVac ÜBERRASCHT Anleger: Insider kaufen massenhaft Anteile - Sofortiges HANDELN erforderlich!!! | ||
MODERNA | 25,800 | -8,35 % | 3 Charts in 3x33 Sekunden - Heute mit Moderna, Silber und RWE | Willkommen zu '3 Charts in 33 Sekunden'! Jörg Scherer stellt uns drei Charts vor, die er aktuell ganz besonders unter die Lupe nimmt. Welche Ziele oder Signale jetzt wichtig sind, erfahren Sie im Video!... ► Artikel lesen | |
STRYKER | 344,30 | -1,80 % | Dividendenbekanntmachungen (31.07.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGNC INVESTMENT CORP US00123Q1040 0,12 USD 0,1051 EUR AGREE REALTY CORPORATION US0084921008 0,256 USD 0,2243 EUR ALLIANT ENERGY... ► Artikel lesen | |
NOVONESIS | 56,70 | -2,00 % | Novonesis (Novozymes A/S): Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe | Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe
A new report reveals that biosolutions could generate EUR 133 billion in economic gains and... ► Artikel lesen | |
DEFENCE THERAPEUTICS | 0,380 | -1,55 % | Defence Therapeutics Inc.: Defence's Accum Technology with ADC and Radiopharmaceutical Programs Target Cancer | Montreal, Quebec--(Newsfile Corp. - July 14, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug... ► Artikel lesen | |
VIVORYON THERAPEUTICS | 1,412 | -0,42 % | Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conferences | Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conferences
Halle (Saale) / Munich, Germany, June 27, 2025 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon)... ► Artikel lesen | |
NUREXONE BIOLOGIC | 0,469 | +5,16 % | Breaking News: ExoPTEN von NurExone auf der Weltbühne! | ||
HALOZYME THERAPEUTICS | 53,38 | +1,48 % | Halozyme Therapeutics, Inc.: European Commission Approved DARZALEX Faspro for Adult Patients with Smouldering Multiple Myeloma | DARZALEX Faspro® is co-formulated with Halozyme's ENHANZE® drug delivery technology
Approval represents critical advancement in early intervention for multiple myeloma
... ► Artikel lesen | |
XOMA ROYALTY | 22,200 | -1,77 % | ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction | SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC and BOSTON and EMERYVILLE, Calif., July 14, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ:... ► Artikel lesen | |
AFFIMED | 0,972 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.05.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.05.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.05.2025ISIN NameBMG3728V1090 GAN... ► Artikel lesen | |
CYTODYN | 0,228 | +4,59 % | CytoDyn files $100M mixed securities shelf | ||
TME PHARMA | 0,111 | 0,00 % | TME Pharma N.V.: TME Pharma Provides Update About Additional Strategy | Regulatory News:
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for cancer and eye diseases, is pleased... ► Artikel lesen | |
CANSINO BIOLOGICS | 4,914 | -4,58 % | CanSino Biologics Inc: CanSinoBIO Launches its Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health | HONG KONG, June 20, 2025 - (ACN Newswire) - Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening illness. It is also the single... ► Artikel lesen | |
NOVOCURE | 10,505 | +9,15 % | Novocure Reports Second Quarter 2025 Financial Results | Quarterly net revenues of $159 million, up 6% year-over-year, with 4,331 active patients on therapy as of June 30, 2025 Results from Phase 3 PANOVA-3 clinical trial presented at 2025 ASCO Annual... ► Artikel lesen |